EUVIMEDEUVIMED entdecken
Crossref

Evaluating the causal effect of medication adherence on adverse clinical outcomes in the target trial framework

Avik Ray iD, Julie C Lauffenburger, Rishi J Desai

International Journal of Pharmacy Practice · 22.07.2026

DOI: 10.1093/ijpp/riag093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 22.07.2026. Verfasst von Avik Ray und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 0…. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School/Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School/Brigham and Women’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We sought to evaluate the causal effect of adherence to Sacubitril/Valsartan (SAC/VAL) on adverse clinical outcomes in patients with heart failure (HF) with reduced ejection fraction, employing methods designed to minimize biases observed in earlier studies.

Methods

Medicare Fee-For-Service claims data was utilized to emulate a target trial comparing two strategies of adherence to SAC/VAL: (a) continued adherence, (b) continued non-adherence. Patients with proportion of days covered ≥80% during an adherence assessment period of 60 days post-initiation were categorized as the continued adherence group, while those with a proportion of days covered <80% were categorized as the continued non-adherence group. Adherence was measured monthly, and patients were censored upon deviating from their strategy. HF hospitalization or all-cause mortality over 1 year was assessed. Marginal structural models with inverse probability treatment weighting to estimate hazard ratios (HRs), while accounting for both baseline and time-varying confounders were employed. A bias calibration analysis using osteoporotic fractures as a negative control outcome accounted for residual bias. Key findings A total of 42 915 individuals were identified in the continued adherence group and 19 782 in the continued non-adherence group. The unadjusted HR for continued adherence vs. continued non-adherence for the composite outcome was 0.52(95% CI, 0.50–0.55). After adjusting for baseline and time-varying covariates, the HR was 0.59(95% CI, 0.56–0.62). The bias-calibrated HR was 0.77(95% CI, 0.71–0.84), indicating the effect is not fully explained by residual confounding.

Conclusions

Among Medicare beneficiaries with HF newly initiated on SAC/VAL, optimal medication adherence was associated with a substantially lower risk of HF hospitalization or all-cause death. For assessing the causal relationship between medication adherence and clinical outcomes, the target trial framework provides a principled approach to avoid common biases.

Schlagwörter

Stichwörter der Autor:innen

Congestive Heart Diseasecausal inferenceclinical outcomesheart failuremedication adherencepatient behaviourpharmacoepidemiologytarget trial framework

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, United States.

ORCID-Profile: Avik Ray

Förderung

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School/Brigham and Women's Hospital
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School/Brigham and Women’s Hospital

Zitieren

APA

Ray, A., Lauffenburger, J. C., & Desai, R. J. (2026). Evaluating the causal effect of medication adherence on adverse clinical outcomes in the target trial framework. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riag093

Vancouver

Ray A, Lauffenburger JC, Desai RJ. Evaluating the causal effect of medication adherence on adverse clinical outcomes in the target trial framework. International Journal of Pharmacy Practice. 2026. doi:10.1093/ijpp/riag093

BibTeX
@article{Ray2026,
  author = {Ray, Avik and Lauffenburger, Julie C and Desai, Rishi J},
  title = {Evaluating the causal effect of medication adherence on adverse clinical outcomes in the target trial framework},
  journal = {International Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1093/ijpp/riag093}
}
Kostenlos starten →